FIVE PRIME THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)

"duration_2025-01-15_to_2025-01-15">8-K
 
 CURRENT REPORT
 Pursuant to Section 13 or 15(d)
 of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): January 15, 2020
 
Five Prime Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
 
 Share
        

                                            © Acquiremedia - 2020